肝纤维化治疗研究进展

[1] Remission of liver fibrosis by interferon alpha 2b. Moreno MG,Muriel P. Biochemical Pharmacology . 1995

[2] I n vivo inhibition of rat stellate cell activation by soluble transforming growth factor type Ⅱ receptor: A potential new therapy for hepatic fibrosis. George J,Roulot D,Koteliansky VE,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999

[3] An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Wynn TA,Cheever AW,Jankovic D,et al. Nature . 1995

[4] An IL-13 inhibitor blocks the development of hepatic fibrosis during a Thelper type 2-dominated inflammatory response. Chiaramonte MG,Donaldson DD,Cheever AW,et al. The Journal of Clinical Investigation . 1999

[5] Reversal of advanced liver fibrosis in rabbits with Schistosomiasis japonica. Dunn MA,Cheever AW,Paglia LM,et al. American Journal of Tropical Medicine and Hygiene . 1994

[6] OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats. Ueno T,Sujaku k,Tamaki S,et al. International Journal of Molecular Medicine . 1999

[7] Nutural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Border WA,Noble NA,Yamamoto T,et al. Nature . 1992

[8] Enhanced interstitial collagenase ( matrix metalloproteinase-13 ) production of kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Hironaka K,Sakaida I,Matsumura Y,et al. Biochemical and Biophysical Research Communications . 2000

[9] Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. Gasso M,Rubio M,Varela G,et al. Journal of Hepatology . 1996

[10] Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. Matsumura Y,Sakaida I,Uchida K,et al. Journal of Hepatology . 1997

[1] Remission of liver fibrosis by interferon alpha 2b. Moreno MG,Muriel P. Biochemical Pharmacology . 1995

[2] I n vivo inhibition of rat stellate cell activation by soluble transforming growth factor type Ⅱ receptor: A potential new therapy for hepatic fibrosis. George J,Roulot D,Koteliansky VE,et al. Proceedings of the National Academy of Sciences of the United States of America . 1999

[3] An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Wynn TA,Cheever AW,Jankovic D,et al. Nature . 1995

[4] An IL-13 inhibitor blocks the development of hepatic fibrosis during a Thelper type 2-dominated inflammatory response. Chiaramonte MG,Donaldson DD,Cheever AW,et al. The Journal of Clinical Investigation . 1999

[5] Reversal of advanced liver fibrosis in rabbits with Schistosomiasis japonica. Dunn MA,Cheever AW,Paglia LM,et al. American Journal of Tropical Medicine and Hygiene . 1994

[6] OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats. Ueno T,Sujaku k,Tamaki S,et al. International Journal of Molecular Medicine . 1999

[7] Nutural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Border WA,Noble NA,Yamamoto T,et al. Nature . 1992

[8] Enhanced interstitial collagenase ( matrix metalloproteinase-13 ) production of kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Hironaka K,Sakaida I,Matsumura Y,et al. Biochemical and Biophysical Research Communications . 2000

[9] Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. Gasso M,Rubio M,Varela G,et al. Journal of Hepatology . 1996

[10] Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. Matsumura Y,Sakaida I,Uchida K,et al. Journal of Hepatology . 1997